Find policies, billing codes, payers, states, and providers

CPT 87253: Viral Identification After Tissue Culture

CPT code 87253 captures confirmatory virology work in which an analyst applies additional tests (such as neutralization) to specifically identify a virus isolated by tissue culture. This code matters nationally because confirmatory identification supports accurate diagnosis, public health surveillance, infection control decisions, and appropriate patient management when initial culture results are inconclusive or require specification.

Key payers commonly involved in coverage and reimbursement for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a succinct explanation of the clinical and laboratory context for 87253, practical notes on where the service is delivered, and what stakeholders typically consider when evaluating claims for specialized virology identification.

The publication summarizes benchmarks and billing context for confirmatory virology testing, highlights clinical scenarios that prompt additional identification steps after tissue culture isolation, and outlines policy-relevant topics such as laboratory service classification and payer coverage considerations. Data not provided in the input (for example, utilization rates, reimbursement amounts, and associated taxonomies or ICD-10 mappings) are noted as unavailable.

Customize your policy alerts

Sign up for cpt 87253 policy alerts

Get alerted when payer policies referencing 87253 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

CPT code 87253 describes laboratory procedures in which a lab analyst performs additional virology tests (for example, neutralization) to specifically identify a virus from a patient specimen that was previously isolated and provisionally identified using tissue culture methodology.

Service type: Specialized virology identification testing involving confirmatory serologic or neutralization assays performed after initial virus isolation.
Typical site of service: Clinical virology laboratories or reference laboratories with tissue culture capability and confirmatory testing workflows.

Data not available in the input.

Find policies, billing codes, payers, states, and providers

CPT 87253: Viral Identification After Tissue Culture

Customize your policy alerts

Sign up for cpt 87253 policy alerts

Get alerted when payer policies referencing 87253 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Specialized virology identification testing involving confirmatory serologic or neutralization assays performed after initial virus isolation.
Typical site of service: Clinical virology laboratories or reference laboratories with tissue culture capability and confirmatory testing workflows.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A virology laboratory receives a nasopharyngeal specimen from an inpatient with an acute viral syndrome. The specimen is processed and inoculated into appropriate cell lines for tissue culture; a laboratory analyst observes cytopathic effect and performs initial identification using immunofluorescence or rapid antigen techniques. To achieve definitive typing and confirm the viral agent, a second analyst performs additional, specific assays such as neutralization testing or targeted serologic neutralization to identify the virus strain isolated in culture. Typical workflow: specimen accessioning → culture inoculation and incubation → primary identification by the first analyst → referral to a virology specialist or second analyst for neutralization or other confirmatory tests (87253) → result verification and reporting to the ordering clinician. Typical site of service is an outpatient or hospital clinical virology laboratory within a medical center or reference laboratory. A realistic patient scenario: a hospitalized adult with fever, respiratory distress, and radiographic infiltrates whose nasopharyngeal swab yields a cytopathic effect in tissue culture; the lab performs neutralization to specifically identify influenza A subtype or adenovirus serotype for infection control and epidemiologic reporting.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component of the test if the physician/lab professional provides interpretation separate from the technical component.
`59`	Distinct procedural service	Use to indicate a separate and distinct laboratory service when multiple procedures are performed on the same specimen and medical necessity supports separate reporting.
`90`	Reference (outside) laboratory	Use when the test is performed by an outside/reference laboratory and billed by the performing lab or when reporting that an external lab performed the work.
`91`	Repeat clinical diagnostic laboratory test	Use when a repeat test is performed on the same patient to obtain subsequent values, if clinically justified.
`TC`	Technical component	Use when billing only the technical component of the test (laboratory processing, culture maintenance) separate from professional interpretation.
`22`	Increased procedural services	Use when the laboratory documents significantly greater effort or complexity than usual for the neutralization/identification procedure.
`52`	Reduced services	Use when the service performed is partially reduced or not completed as documented.
`53`	Discontinued procedure	Use when testing is started but discontinued due to specimen failure or other documented reasons.
`78`	Unplanned return to the operating/procedure room by the same physician following initial procedure	Rare for lab codes but may be used analogously when an unplanned repeat procedural intervention is required for the same episode (use per payer rules).
`90`	Reference (outside) laboratory	Use when an external reference laboratory performed the specialized neutralization testing (listed again here because of frequent applicability).

Taxonomy Code	Specialty	Notes
3336S	Clinical Laboratory Immunology	Specialists performing viral neutralization and serologic identification.
253K00000X	Pathology & Laboratory Medicine	Clinical pathologists who oversee virology laboratory testing.
207R00000X	Infectious Disease	Infectious disease physicians who order and interpret virology identification for patient care.
363L00000X	Medical Technologist	Medical technologists/clinical laboratory scientists who perform tissue culture and neutralization assays.
362A00000X	Microbiology	Laboratory microbiologists focused on viral isolation and typing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J12.89`	Other viral pneumonia	Viral isolates from respiratory specimens often require tissue culture and neutralization for definitive identification.
`J10.1`	Influenza due to identified seasonal influenza virus with other respiratory manifestations	Subtyping or serotyping by neutralization may be performed after culture isolation to identify influenza strain.
`B97.89`	Other viral agents as the cause of diseases classified elsewhere	Used when a specific viral agent identified by neutralization is the causal organism for a condition.
`B34.9`	Viral infection, unspecified	When initial clinical presentation suggests viral infection and culture with neutralization is used for specific identification.
`A49.9`	Bacterial infection, unspecified site (included when co-infection suspected)	May be listed when differential includes bacterial pathogens and culture-based workflows are used to distinguish etiologies; laboratory testing helps exclude bacterial causes.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87252`	Culture, fungal, bacterial or viral; isolation/identification by tissue culture, initial isolation	Performed before `87253`; the initial tissue culture isolation and preliminary identification by the first analyst precedes additional specific neutralization testing.
`87254`	Tissue culture, cytopathic effect observation only	May be used for documentation of culture observation steps; relates to the culture process that yields isolates for `87253` confirmatory testing.
`87256`	Viral identification by immunofluorescence or antigen detection (direct or indirect)	Often performed as initial identification methods; if these methods are inconclusive, `87253` neutralization is performed for specific identification.
`87498`	Infectious agent detection by nucleic acid, unspecified method, amplified probe technique	Molecular tests that may be ordered alongside or instead of culture-based identification; provides complementary or confirmatory results to culture and neutralization.
`88360`	Special stains (e.g., for infectious agents)	Ancillary pathology techniques that may be used in parallel for identification of infectious organisms in tissue; supports diagnostic correlation with `87253`.

CPT 87250: Viral Isolation in Embryonated Egg or Small Animal

CPT-87252-VIRAL-CULTURE-IDENTIFICATION-TISSUE-CULTURE

CPT 87252: Viral Culture Identification by Tissue Culture

CPT-87254-SHELL-VIAL-VIRAL-CULTURE-IMMUNOFLUORESCENCE

CPT 87254: Shell Vial Viral Culture with Immunofluorescence

CPT-87255-VIRAL-IDENTIFICATION-CELL-IMPACT-ANALYSIS

CPT 87255: Viral Identification by Cell Impact Analysis

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component of the test if the physician/lab professional provides interpretation separate from the technical component.
`59`	Distinct procedural service	Use to indicate a separate and distinct laboratory service when multiple procedures are performed on the same specimen and medical necessity supports separate reporting.
`90`	Reference (outside) laboratory	Use when the test is performed by an outside/reference laboratory and billed by the performing lab or when reporting that an external lab performed the work.
`91`	Repeat clinical diagnostic laboratory test	Use when a repeat test is performed on the same patient to obtain subsequent values, if clinically justified.
`TC`	Technical component	Use when billing only the technical component of the test (laboratory processing, culture maintenance) separate from professional interpretation.
`22`	Increased procedural services	Use when the laboratory documents significantly greater effort or complexity than usual for the neutralization/identification procedure.
`52`	Reduced services	Use when the service performed is partially reduced or not completed as documented.
`53`	Discontinued procedure	Use when testing is started but discontinued due to specimen failure or other documented reasons.
`78`	Unplanned return to the operating/procedure room by the same physician following initial procedure	Rare for lab codes but may be used analogously when an unplanned repeat procedural intervention is required for the same episode (use per payer rules).
`90`	Reference (outside) laboratory	Use when an external reference laboratory performed the specialized neutralization testing (listed again here because of frequent applicability).

Taxonomy Code	Specialty	Notes
3336S	Clinical Laboratory Immunology	Specialists performing viral neutralization and serologic identification.
253K00000X	Pathology & Laboratory Medicine	Clinical pathologists who oversee virology laboratory testing.
207R00000X	Infectious Disease	Infectious disease physicians who order and interpret virology identification for patient care.
363L00000X	Medical Technologist	Medical technologists/clinical laboratory scientists who perform tissue culture and neutralization assays.
362A00000X	Microbiology	Laboratory microbiologists focused on viral isolation and typing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J12.89`	Other viral pneumonia	Viral isolates from respiratory specimens often require tissue culture and neutralization for definitive identification.
`J10.1`	Influenza due to identified seasonal influenza virus with other respiratory manifestations	Subtyping or serotyping by neutralization may be performed after culture isolation to identify influenza strain.
`B97.89`	Other viral agents as the cause of diseases classified elsewhere	Used when a specific viral agent identified by neutralization is the causal organism for a condition.
`B34.9`	Viral infection, unspecified	When initial clinical presentation suggests viral infection and culture with neutralization is used for specific identification.
`A49.9`	Bacterial infection, unspecified site (included when co-infection suspected)	May be listed when differential includes bacterial pathogens and culture-based workflows are used to distinguish etiologies; laboratory testing helps exclude bacterial causes.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87252`	Culture, fungal, bacterial or viral; isolation/identification by tissue culture, initial isolation	Performed before `87253`; the initial tissue culture isolation and preliminary identification by the first analyst precedes additional specific neutralization testing.
`87254`	Tissue culture, cytopathic effect observation only	May be used for documentation of culture observation steps; relates to the culture process that yields isolates for `87253` confirmatory testing.
`87256`	Viral identification by immunofluorescence or antigen detection (direct or indirect)	Often performed as initial identification methods; if these methods are inconclusive, `87253` neutralization is performed for specific identification.
`87498`	Infectious agent detection by nucleic acid, unspecified method, amplified probe technique	Molecular tests that may be ordered alongside or instead of culture-based identification; provides complementary or confirmatory results to culture and neutralization.
`88360`	Special stains (e.g., for infectious agents)	Ancillary pathology techniques that may be used in parallel for identification of infectious organisms in tissue; supports diagnostic correlation with `87253`.

CPT 87250: Viral Isolation in Embryonated Egg or Small Animal

CPT-87252-VIRAL-CULTURE-IDENTIFICATION-TISSUE-CULTURE

CPT 87252: Viral Culture Identification by Tissue Culture

CPT-87254-SHELL-VIAL-VIRAL-CULTURE-IMMUNOFLUORESCENCE

CPT 87254: Shell Vial Viral Culture with Immunofluorescence

CPT-87255-VIRAL-IDENTIFICATION-CELL-IMPACT-ANALYSIS

CPT 87255: Viral Identification by Cell Impact Analysis

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

CPT 87253: Viral Identification After Tissue Culture

Sign up for cpt 87253 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

CPT 87253: Viral Identification After Tissue Culture

Sign up for cpt 87253 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References